Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Lips

Showing results (31-40 of 121) with videos related to

Pageof 13
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|April 14, 2016
[Ductal carcinoma in situ: the balance between over- and undertreatment]Emma J Groen, Lotte E Elshof, Emiel J Th Rutgers, et al.
Iscience|May 24, 2024
Predicting treatment outcome using kinome activity profiling in HER2+ breast cancer biopsiesDonna O Debets, Erik L de Graaf, Marte C Liefaard, et al.
Future Oncology (London, England)|December 16, 2024
An early economic evaluation of active surveillance for low-risk ductal carcinoma <i>in situ</i>Danalyn Byng, Michael Schaapveld, Esther H Lips, et al.
Genome Research|February 3, 2007
High-resolution copy number analysis of paraffin-embedded archival tissue using SNP BeadArraysJan Oosting, Esther H Lips, Ronald van Eijk, et al.
Cell Reports. Medicine|October 5, 2023
Deep (phospho)proteomics profiling of pre- treatment needle biopsies identifies signatures of treatment resistance in HER2<sup>+</sup> breast cancerDonna O Debets, Kelly E Stecker, Anastasia Piskopou, et al.
Breast (Edinburgh, Scotland)|September 28, 2016
Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS)Emma J Groen, Lotte E Elshof, Lindy L Visser, et al.
Breast Cancer Research and Treatment|July 6, 2013
Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy responseE H Lips, L Mulder, J J de Ronde, et al.
Breast Cancer Research : BCR|July 27, 2020
BRCAness digitalMLPA profiling predicts benefit of intensified platinum-based chemotherapy in triple-negative and luminal-type breast cancerEsther H Lips, Anne Benard-Slagter, Mark Opdam, et al.
British Journal of Cancer|July 24, 2023
Correction To: Tumour-educated platelets for breast cancer detection: biological and technical insightsMarte C Liefaard, Kat S Moore, Lennart Mulder, et al.
British Journal of Cancer|February 10, 2023
Tumour-educated platelets for breast cancer detection: biological and technical insightsMarte C Liefaard, Kat S Moore, Lennart Mulder, et al.
Pageof 13

Showing results (31-40 of 121) with videos related to

Sort By:
Pageof 13
Nederlands Tijdschrift Voor Geneeskunde|April 14, 2016
[Ductal carcinoma in situ: the balance between over- and undertreatment]Emma J Groen, Lotte E Elshof, Emiel J Th Rutgers, et al.
Iscience|May 24, 2024
Predicting treatment outcome using kinome activity profiling in HER2+ breast cancer biopsiesDonna O Debets, Erik L de Graaf, Marte C Liefaard, et al.
Future Oncology (London, England)|December 16, 2024
An early economic evaluation of active surveillance for low-risk ductal carcinoma <i>in situ</i>Danalyn Byng, Michael Schaapveld, Esther H Lips, et al.
Genome Research|February 3, 2007
High-resolution copy number analysis of paraffin-embedded archival tissue using SNP BeadArraysJan Oosting, Esther H Lips, Ronald van Eijk, et al.
Cell Reports. Medicine|October 5, 2023
Deep (phospho)proteomics profiling of pre- treatment needle biopsies identifies signatures of treatment resistance in HER2<sup>+</sup> breast cancerDonna O Debets, Kelly E Stecker, Anastasia Piskopou, et al.
Breast (Edinburgh, Scotland)|September 28, 2016
Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS)Emma J Groen, Lotte E Elshof, Lindy L Visser, et al.
Breast Cancer Research and Treatment|July 6, 2013
Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy responseE H Lips, L Mulder, J J de Ronde, et al.
Breast Cancer Research : BCR|July 27, 2020
BRCAness digitalMLPA profiling predicts benefit of intensified platinum-based chemotherapy in triple-negative and luminal-type breast cancerEsther H Lips, Anne Benard-Slagter, Mark Opdam, et al.
British Journal of Cancer|July 24, 2023
Correction To: Tumour-educated platelets for breast cancer detection: biological and technical insightsMarte C Liefaard, Kat S Moore, Lennart Mulder, et al.
British Journal of Cancer|February 10, 2023
Tumour-educated platelets for breast cancer detection: biological and technical insightsMarte C Liefaard, Kat S Moore, Lennart Mulder, et al.
Pageof 13